Document Type : Case Report(s)
Authors
- Andrey Gaiday 1
- Akylbek Tussupkaliyev 1
- Abay Nurken 2
- Assel Gaiday 2
- Ainur Primbetova 2
- Moldir Dossimbetova 1
- Assemgul Yeszhanova 2
- Bibigul Karimsakova 3
- Nurgul Ablakimova 4, 5
1 Department of Obstetrics and Gynecology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
2 Department of Gynecology, Regional Perinatal Center, Aktobe, Kazakhstan
3 Department of General Medical Practice, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
4 Department of Pharmacology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
5 Department of Hospital Pharmacy, Regional Perinatal Center, Aktobe, Kazakhstan
Abstract
The incidence of ectopic pregnancy (EP) has increased in recent years, owing to causes such as pelvic inflammatory diseases and assisted reproductive technologies (ART). The present study reported a case of a 33-year-old nulliparous woman with a history of previous ectopic pregnancies, who underwent pelvic ultrasound in August 2022, which revealed a double EP including a cervical pregnancy and a tubal stump pregnancy. Despite known risk factors and elevated beta-human chorionic gonadotropin (β-hCG) levels, a conservative approach, utilizing multiple doses of systemic methotrexate (MTX) injections, was employed to preserve fertility at the Regional Perinatal Center in Aktobe, Kazakhstan. Treatment efficacy was monitored through β-hCG levels and ultrasound imaging, with successful resolution of both EPs and preservation of reproductive function. The present case highlighted the safety and efficacy of MTX therapy in managing complex EP presentations, emphasizing the necessity of individualized treatment approaches in reproductive medicine, particularly in terms of preserving fertility in patients undergoing ART. Multiple high doses of MTX injections were beneficial for pregnancy with two distinct regions, fetal cardiac activity, and elevated serum β-hCG level. Further research is required to explore optimal treatment strategies for EP, considering patient-specific factors and treatment goals.
Keywords
- Tonick S, Conageski C. Ectopic Pregnancy. Obstet Gynecol Clin North Am. 2022;49:537-49. doi: 10.1016/j.ogc.2022.02.018. PubMed PMID: 36122984.
- Mullany K, Minneci M, Monjazeb R, O CC. Overview of ectopic pregnancy diagnosis, management, and innovation. Womens Health (Lond). 2023;19:17455057231160349. doi: 10.1177/17455057231160349. PubMed PMID: 36999281; PubMed Central PMCID: PMCPMC10071153.
- Brady PC. New Evidence to Guide Ectopic Pregnancy Diagnosis and Management. Obstet Gynecol Surv. 2017;72:618-25. doi: 10.1097/OGX.0000000000000492. PubMed PMID: 29059454.
- Houser M, Kandalaft N, Khati NJ. Ectopic pregnancy: a resident’s guide to imaging findings and diagnostic pitfalls. Emerg Radiol. 2022;29:161-72. doi: 10.1007/s10140-021-01974-7. PubMed PMID: 34618256.
- Cheng LY, Lin PY, Huang FJ, Kung FT, Chiang HJ, Lin YJ, et al. Ectopic pregnancy following in vitro fertilization with embryo transfer: A single-center experience during 15 years. Taiwan J Obstet Gynecol. 2015;54:541-5. doi: 10.1016/j.tjog.2015.08.004. PubMed PMID: 26522107.
- Zikopoulos A, Loukopoulos T, Galani A, Kechagias K, Skentou C, Zikopoulos K, et al. Methotrexate treatment of very high beta-HCG ectopic pregnancy on previous cesarean scar: A case report. Radiol Case Rep. 2023;18:4106-9. doi: 10.1016/j.radcr.2023.08.051. PubMed PMID: 37720917; PubMed Central PMCID: PMCPMC10504459.
- Dilday E, Douglas C, Brennan K. Single-dose intramuscular methotrexate for treatment of cervical ectopic pregnancy: A case report. Case Rep Womens Health. 2021;31:e00340. doi: 10.1016/j.crwh.2021.e00340. PubMed PMID: 34336601; PubMed Central PMCID: PMCPMC8313574.
- Naveed AK, Anjum MU, Hassan A, Mahmood SN. Methotrexate versus expectant management in ectopic pregnancy: a meta-analysis. Arch Gynecol Obstet. 2022;305:547-53. doi: 10.1007/s00404-021-06236-y. PubMed PMID: 34524502.
- Agha RA, Franchi T, Sohrabi C, Mathew G, Kerwan A, Group S. The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines. Int J Surg. 2020;84:226-30. doi: 10.1016/j.ijsu.2020.10.034. PubMed PMID: 33181358.
- American College of O, Gynecologists’ Committee on Practice B-G. ACOG Practice Bulletin No. 193: Tubal Ectopic Pregnancy. Obstet Gynecol. 2018;131:e91-e103. doi: 10.1097/AOG.0000000000002560. PubMed PMID: 29470343.
- Stabile G, Romano F, Buonomo F, Zinicola G, Ricci G. Conservative Treatment of Interstitial Ectopic Pregnancy with the Combination of Mifepristone and Methotrexate: Our Experience and Review of the Literature. Biomed Res Int. 2020;2020:8703496. doi: 10.1155/2020/8703496. PubMed PMID: 32802882; PubMed Central PMCID: PMCPMC7421079.
- Alfiya R, Sabu ST, Dharan SS. A detailed study of methotrexate treatment in ectopic pregnancy. Int J Res Hosp Clin Pharm. 2020;2:85-92. doi: 10.33974/ijrhcp.v2i4.252.
- Vrees RA, Frishman GN. Nontubal Ectopic Pregnancy. In: Keder L, Olsen ME, editors. Gynecologic Care. Cambridge: Cambridge University; 2018. p. 162-74. doi: 10.1017/9781108178594.018.
- Drezett J, Marques D, Ottoboni R, Dzik A, Cavagna M. Cervical ectopic pregnancy after in vitro fertilization: case report successfully treated with cervical electric aspiration. JBRA Assist Reprod. 2019;23:434-8. doi: 10.5935/1518-0557.20190036. PubMed PMID: 31251012; PubMed Central PMCID: PMCPMC6798596.
- Onda K, Honma T, Masuyama K. Methotrexate-related adverse events and impact of concomitant treatment with folic acid and tumor necrosis factor-alpha inhibitors: An assessment using the FDA adverse event reporting system. Front Pharmacol. 2023;14:1030832. doi: 10.3389/fphar.2023.1030832. PubMed PMID: 36909171; PubMed Central PMCID: PMCPMC9992735.
)